Wallroth Donald E. 4
4 · Molecular Insight Pharmaceuticals, Inc. · Filed May 26, 2009
Insider Transaction Report
Form 4
Wallroth Donald E.
Chief Financial Officer
Transactions
- Sale
Common Stock
2009-05-22$3.80/sh−4,000$15,186→ 16,000 total - Sale
Common Stock
2009-05-22$3.75/sh−2,500$9,376→ 13,500 total